An upward spiral

The trading of credit derivatives has rocketed in Asia over the past two years. As a result, banks are looking for data and risk management tools, and a number of brokerages and software firms are stepping up to the challenge. Clive Davidson reports

cd-1-gif

The credit derivatives markets in Asia have grown dramatically over the past two years. Deutsche Bank, for example, reports more than 100% increase in its trade by volume in the Japanese market during the period, while interest in instruments such as synthetic collateralised debt obligations (CDOs) is picking up across the region. As such, the need for pricing and risk management tools for credit derivatives is also on the rise. Although most global banks are using their own technology to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here